Work

Non-muscle myosin II is associated with poor prognosis and represents a potential therapeutic target in HER2-immunoreactive breast cancer

Year: 2026
Type: other
Abstract: Supplementary Molecular Docking and Molecular Dynamics Simulation Dataset for the Manuscript: Non-muscle myosin II is associated with poor prognosis and represents a potential therapeutic target in HER2-immunoreactive breast cancer Wasim Feroz1, Arif Hossin2, Andrew Stiles3, Sarah Storr4, Sonia Amoah1, Mary Kate Kilroy-Gehret 1, Sidharth Gadgil1, Rosalin Mishra1, Andrew R. Green4, Ian O. Ellis4, Emad A. Rakha4, Courtney Miller5, George Stan2, Joan T. Garrett1 1James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA 2Department of Chemistry, University of Cincinnati, Cincinnati, Ohio 45267, USA 3Cancer Research Scholars Program, College of Allied Health Sciences, University of Cincinnati, Cincinnati, OH 45267, USA. 4Nottingham Breast Cancer Research Centre, School of Medicine, University of Nottingham Biodiscovery Institute, University Park, Nottingham, NG7 2RD, UK 5Departments of Molecular Medicine and Neuroscience, The Herbert Wertheim UF Scripps Institute for Biomedical Innovation & Technology, Jupiter, FL 33458, USA Corresponding author information: Joan T. Garrett, Email: [email protected]
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7221777187
Cites:
Cited by:
Related to: 10